Training Example: UBRELVY (AbbVie) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

[H1] THE ANYTIME, ANYWHERE
MIGRAINE MEDICINE™

[H2] Over 1.4 million patients have been
prescribed UBRELVY as of 12/25.

[H2] UBRELVY IS PROVEN TO TREAT MIGRAINE ATTACKS
[H3] When migraine strikes, do you ask yourself if the tradeoffs of treating are worth it? Do you think maybe you'll just push through the pain? UBRELVY can be another option.

[H4] Migraine Pain Relief
Most have fast migraine pain relief within 2 hours.†

†60% of people had migraine pain relief within 2 hours.

[H4] Anytime, Anywhere
UBRELVY can treat migraine attacks without having to worry if it’s too late‡ to take it or where you are.

‡People took UBRELVY within 4 hours of a migraine attack.

[H4] Few People Had Side Effects
The most common side effects were nausea (2-4%) and sleepiness (2-3%).

[H2] WHEN IT COMES TO MIGRAINE ATTACKS, ARE YOU…

Treating with UBRELVY
Taking oral triptans
Treating with over-the-counter medications
Experiencing early signs of a migraine attack before head pain starts
Wanting to learn more about migraine

Treating with UBRELVY?
Savings Learn how you can start saving on your prescription with the UBRELVY Complete Savings Card.
Resources Find all the information you need about UBRELVY, the Anytime, Anywhere Migraine Medicine.

Taking oral triptans?
Treating Migraine Learn more about migraine attacks and how to treat them.
UBRELVY Challenge If you’re currently taking an oral triptan, learn more about the UBRELVY Challenge.

Treating with over-the-counter medications?
Treating Migraine Learn more about migraine attacks and how to treat them.
Doctor Discussion Guide Want to talk about treatment with your doctor but don’t know where to start? Explore our discussion guide and start the conversation today.

Experiencing early signs of a migraine attack before head pain starts?
Early Signs Learn more about identifying and treating at the early signs of a migraine attack—before head pain starts.
Why UBRELVY Learn how UBRELVY can help treat migraine attacks.

Wanting to learn more about migraine?
Treating Migraine Learn more about migraine attacks and how to treat them.
Frequently Asked Questions Get your questions about migraine and UBRELVY answered.

back to options

[H2] save on ubrelvy

ENROLL NOW
[H3] Eligible Patients Pay as
Little as $0* a Month
See if you're eligible to pay as little as $0* for every fill with the UBRELVY Complete Savings Card.

START SAVING

UBRELVY CHALLENGE
[H3] TAKING AN ORAL TRIPTAN
FOR MIGRAINE?
If you're an eligible commercially insured patient taking a triptan, you can try UBRELVY by registering for the UBRELVY Challenge. If it’s not for you, we’ll cover your next oral triptan fill for $0§ before the offer expires.

START THE CHALLENGE

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance.  For full Terms and Conditions, visit UBRELVY.com/savings-terms or call 1-844-482-7358 for more information. To learn about AbbVie's privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.

§Offer not available to patients enrolled in Medicare, Medicaid, or any other federal or state healthcare programs. Restrictions, including savings maximums, apply. Patient out-of-pocket expense will vary depending on insurance coverage. UBRELVY coupon becomes valid upon activation of offer. Oral triptan medication coupon becomes valid two (2) weeks from activation of offer and expires six (6) weeks from activation of offer. For full Terms and Conditions, visit ubrelvy.com/challenge-terms or call 1-844-482-7358 for more information.
No head-to-head studies have been conducted between UBRELVY and triptans; therefore, no conclusions regarding safety or efficacy can be drawn.

[H2] Wondering if you can take UBRELVY for migraine attacks before head pain starts?

LEARN ABOUT TREATING AT EARLY SIGNS

[H2] Want to ask a specialist about UBRELVY?

[H3] Talk to a Doctor Online
Get answers to your questions, discuss treatment options, and learn how to manage your symptoms better—all from the comfort of your home.

talk now

[H3] Find a Provider Near You
Use our search tool to locate healthcare providers in your area who can help manage your migraine attacks.

start your search

[IMG: icon quote left]
[H2] I’ve been looking for something like this for so long.
KENDALL
Real UBRELVY patient

hear more stories

[H3] be in the know
Get the latest UBRELVY updates sent straight to your inbox.

sign up

[H3] Why UBRELVY?
Discover why UBRELVY is the #1 prescribed branded treatment for migraine attacks.

why ubrelvy

IMPORTANT SAFETY INFORMATION
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Have high blood pressure
Have circulation problems in your fingers and toes
Have liver problems
Have kidney problems
Are pregnant or plan to become pregnant
Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100

Please see full Patient Information.

[H2] SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU
Use telemedicine to connect to a doctor. Here's how:

[IMG: chat bubbles icon]
Answer a few simple questions about your migraine attacks and current treatment plan.
[IMG: stethoscope inside phone icon]
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
[IMG: rx paper icon]
If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW

BACK TO SITE

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H1]

US-UBR-250117

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

This offer is valid for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient.
This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. If at any time a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for this program and must cease participation. This offer is not valid for cash-paying patien

CGRP DURING A MIGRAINE ATTACK
MIGRAINE ATTACK WITH UBRELVY

[H1] why ubrelvy

UBRELVY is proven to treat migraine attacks

[H2] UBRELVY can provide:

[H4] Migraine Pain Relief
Most have fast migraine pain relief within 2 hours.**60% of people had migraine pain relief within 2 hours.

[H4] Few People Had Side Effects
The most common side effects were nausea (2-4%) and sleepiness (2-3%).

[H2] HERE’S THE SCIENCE:
UBRELVY is an oral, non-narcotic medication taken at the onset of a migraine attack. As a member of a new class of acute treatments for migraine attacks, it is the first medication specifically designed and approved to treat attacks as they occur. It works by directly blocking the receptor for a protein called CGRP, which is believed to trigger pain and inflammation during migraine attacks.

[H4] When Migraine Strikes
CGRP is released, binding to receptors and triggering pain and inflammation.

[H4] What UBRELVY Does
UBRELVY blocks CGRP from binding to the receptors.

[H4] The UBRELVY Effect
By blocking the receptors, UBRELVY acts at a major source of inflammation and pain during a migraine attack.

[H3] WHAT UBRELVY OFFERS
[H4] Treatment at Early Signs
UBRELVY can be taken at the early signs of a migraine attack—before head pain starts.
[H4] On-the-Go Packs
Convenient access to treatment wherever you go with On-the-Go Packs.
[H4] Flexible Dosing
Two dosage strengths available that can be taken anytime, anywhere.† If needed, a second dose can be taken 2 hours after the first.†People took UBRELVY within 4 hours of a migraine attack.
[H4] 16-Count Pill Packs
Get more per month with UBRELVY 100 mg 16-count pill packs, so you can treat migraine attacks when you need to. Ask your healthcare provider if the 16-count pill pack is right for you.
Safety of UBRELVY for more than 8 migraine attacks in 30 days is unknown.

[H4] Ready to try UBRELVY to treat your migraine attacks?

talk to a doctor

[H2] UBRELVY CAN HELP TREAT MIGRAINE ATTACKS
including those that happen around the time of your period.

60%
[H4] of Women Who Experience Migraine Attacks
have them during their period.‡ UBRELVY can help treat migraine attacks, including the ones that can happen during your period.
‡Loder EW. Headache 2006;46(Suppl 2):S55-60.

[H4] Starts Around the Time of Periods
That is, before or during your period. Some people get migraine attacks at other times of the month as well.

[H2] with previous medications, i’ve had to make the choice to push through with the migraine. with ubrelvy, that doesn’t happen.
CAT
Real UBRELVY patient

hear more stories

[H3] Be in the know
Get the latest UBRELVY updates sent straight to your inbox.

sign up

[H3] Treating Migraine Attacks
Are you ready for a different migraine treatment?

LEARN MORE

IMPORTANT SAFETY INFORMATION
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Have high blood pressure
Have circulation problems in your fingers and toes
Have liver problems
Have kidney problems
Are pregnant or plan to become pregnant
Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100

Please see full Patient Information.

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

This offer is valid for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient.
This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. If at any time a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for this program and must cease participation. This offer is not valid for cash-paying patients.
Eligible commercially insured patients may pay as little as $0 per monthly prescription fill. Patient out-of-pocket expense will vary; check with your pharmacist for your co-pay discount. Restrictions, including monthly, quarterly, and/or annual maximums, may apply.
Subject to all other terms and conditions, a commercially insured patient whose plan covers UBRELVY may receive up to a maximum annual savings of $7,000 per calendar year, solely for the patient’s benefit, under this program. Commercially insured patients for whom coverage is not available because the insurer has not established a coverage review process may be eligible to receive up to 4 one-month fills at no charge. Under this program, once an insurer has established a review process for coverage requests, commercially insured patients may receive up to a maximum of 2-month fills at no charge for an FDA-approved indication while coverage is pending.
Patients may not seek reimbursement for value received from this savings program from any third-party payers.
AbbVie reserves the right to rescind, revoke, or amend this offer without notice.
Offer good only in the USA, including Puerto Rico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states may not be eligible to participate in this program.
Void if prohibited by law, taxed, or restricted.
This card is not transferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.
This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.
This offer is not health insurance.
By redeeming this offer, you acknowledge that you are an eligible commercially insured patient and that you understand and agree to comply with the above terms and conditions.
For questions about the program, including savings on mail-order prescriptions, or to activate your card ID, please call 1-844-577-6239.
To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy

[H2] SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU
Use telemedicine to connect to a doctor. Here's how:

[IMG: chat bubbles icon]
Answer a few simple questions about your migraine attacks and current treatment plan.
[IMG: stethoscope inside phone icon]
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
[IMG: rx paper icon]
If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW

BACK TO SITE

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H1]

US-UBR-250117

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

This offer is valid for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) table

[H1] Everyone Is Eligible for Personalized Support

Enroll today to get support and resources to help you start and stay on track with your prescribed treatment plan.

ENROLL NOW

[H2] UBRELVY Complete is here for you—at no additional cost

Talk with a live person to answer questions about enrolling, your prescription, or what to expect with UBRELVY

Eligible, commercially insured patients may pay as little as $0* per fill with the UBRELVY Complete Savings Card

Access tools and downloads that are made to help you on your migraine treatment journey.

[H2] Enroll online in just a few minutes

JOIN NOW

Or text† UBRELVY to 48764

Start saving with your first fill at the pharmacy

You may be able to start treatment right away with 2 free fills* of UBRELVY while your insurance company approves your prescription coverage.
Plus, with the UBRELVY Complete Savings Card, eligible, commercially insured patients may pay as little as $0* for each refill.
*For eligible, commercially insured patients only. Please see Terms and Conditions here.

ACCESS SAVINGS SUPPORT

When you have questions, connect with a live person

Talk to one of our live representatives who can help answer questions about insurance coverage, cost, and other topics related to UBRELVY. We can help you enroll in UBRELVY Complete, navigate insurance challenges, and answer questions about your medication.
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.

Call 1.844.4.UBRELVY (1.844.482.7358)

Resources that help you start and stay on track with your prescribed treatment plan

Get the support you need when you need it. Explore tools and resources that help you throughout your migraine treatment.

EXPLORE RESOURCES

UBRELVY CHALLENGE

TAKING AN ORAL TRIPTAN FOR MIGRAINE?

If you're an eligible commercially insured patient taking a triptan, you can try UBRELVY by registering for the UBRELVY Challenge. If it’s not for you, we’ll cover your next oral triptan fill for $0§ before the offer expires.

START THE CHALLENGE

§Offer not available to patients enrolled in Medicare, Medicaid, or any other federal or state healthcare programs. Restrictions, including savings maximums, apply. Patient out-of-pocket expense will vary depending on insurance coverage. UBRELVY coupon becomes valid upon activation of offer. Oral triptan medication coupon becomes valid two (2) weeks from activation of offer and expires six (6) weeks from activation of offer. For full Terms and Conditions, visit ubrelvy.com/challenge-terms or call 1-844-482-7358 for more information.

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY® (ubrogepant) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit UBRELVY.com/savings-terms or call 1-844-482-7358 for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBREVLY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
‡Offer not available to patients enrolled in Medicare, Medicaid, or any other federal or state healthcare programs. Restrictions, including savings maximums, apply. Patient out-of-pocket expense will vary depending on insurance coverage. UBRELVY coupon becomes valid upon activation of offer. Oral triptan medication coupon becomes valid two (2) weeks from activation of offer and expires six (6) weeks from activation of offer. For full Terms and Conditions, visit ubrelvy.com/challenge-terms or call 1-844-577-6239 for more information.

IMPORTANT SAFETY INFORMATION
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Have high blood pressure
Have circulation problems in your fingers and toes
Have liver problems
Have kidney problems
Are pregnant or plan to become pregnant
Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100

Please see full Patient Information.

[H2] SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU
Use telemedicine to connect to a doctor. Here's how:

[IMG: chat bubbles icon]
Answer a few simple questions about your migraine attacks and current treatment plan.
[IMG: stethoscope inside phone icon]
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
[IMG: rx paper icon]
If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW

BACK TO SITE

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

This offer is valid for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient.
This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. If at any time a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for this program and must cease participation. This offer is not valid for cash-paying patients.
Eligible commercially insured patients may pay as little as $0 per monthly prescription fill. Patient out-of-pocket expense will vary; check with your pharmacist for your co-pay discount. Restrictions, including monthly, quarterly, and/or annual maximums, may apply.
Subject to all other terms and conditions, a commercially insured patient whose plan covers UBRELVY may receive up to a maximum annual savings of $7,000 per calendar year, solely for the patient’s benefit, under this program. Commercially insured patients for whom coverage is not available because the insurer has not established a coverage review process may be eligible to receive up to 4 one-month fills at no charge. Under this program, once an insurer has established a review process for coverage requests, commercially insured patients may receive up to a maximum of 2-month fills at no charge for an FDA-approved indication while coverage is pending.
Patients may not seek reimbursement for value received from this savings program from any third-party payers.
AbbVie reserves the right to rescind, revoke, or amend this offer without notice.
Offer good only in the USA, including Puerto Rico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states may not be eligible to participate in this program.
Void if prohibited by law, taxed, or restricted.
This card is not transferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.
This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.
This offer is not health insurance.
By redeeming this offer, you acknowledge that you are an eligible commercially insured patient and that you understand and agree to comply with the above terms and conditions.
For questions about the program, including savings on mail-order prescriptions, or to activate your card ID, please call 1-844-577-6239.
To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division o

[H1] real patient stories

Real Stories.

Real Relief.

Real UBRELVY patient.

[H2] Relief That Resonates
[H3] From managing the toughest migraine attacks to sharing their stories about their experience, see how UBRELVY has made an impact on real patients across the country.

[H2] With other medications I've had to push through the migraine. With UBRELVY that doesn't happen.
CAT
Real UBRELVY patient

[H2] The first time that I took UBRELVY, it kicked the migraine's butt.
BRITTANY
Real UBRELVY patient

[H2] UBRELVY is the first thing that has given me some real relief.
KENDALL
Real UBRELVY patient

[H2] Since I started taking UBRELVY, I can keep going even when I have a migraine attack.
LAURA
Real UBRELVY patient

See More

See Less

[H3]

Transcript

view transcript

[H2] LAURA'S STORY
I would definitely recommend UBRELVY, and you should ask your doctor to see if it’s right for you.
Patients were compensated to share their stories, and were on prescribed therapy when they provided their testimonials. Changes in therapy status may have occurred since that time. Individual results may vary.

[H2] Ask your doctor to see if UBRELVY is right for you.

talk to a doctor

[H3]

Transcript

view transcript

[H2] TRACI'S STORY
You can take it anywhere, anytime... it's always with me.†
†In clinical trials, patients took UBRELVY within 4 hours of a migraine attack.
Patients were compensated to share their stories, and were on prescribed therapy when they provided their testimonials. Changes in therapy status may have occurred since that time. Individual results may vary.

view transcript

[H2] Traci’s story
For Traci, migraine used to mean putting her saxophone away, unsure when she’d play again. Now, Traci recognizes her early signs of migraine and treats with UBRELVY, helping her stay confident and in control. That means more time for the instrument she loves—which is music to our ears.
You can take it anywhere, anytime… it’s always with me.*People took UBRELVY within 4 hours of a migraine attack.

watch traci's story

[H2] We have a treatment plan, we have UBRELVY and migraine can't stop us now.
Lynn
Real UBRELVY patient

[H2] I don't give up any time to migraine. I'm looking forward, I'm hopeful for the future.
Cat
Real UBRELVY patient

[H2] I can't imagine not having UBRELVY on me.
Ginger
Real UBRELVY patient

[H2] It's the first thing that has given me some real relief.
Kendall
Real UBRELVY patient

[H2] I can take it anywhere, anytime and it can stop migraine pain within 2 hours.†
†Can provide pain freedom within 2 hours. People took UBRELVY within 4 hours of a migraine attack.
Carlie
Real UBRELVY patient

[H2] I have UBRELVY within reach wherever I am.
Cat
Real UBRELVY patient

[H2] Want to ask a specialist about UBRELVY?

[H3] Talk to a Doctor Online
Get answers to your questions, discuss treatment options, and learn how to manage your symptoms better—all from the comfort of your home.

talk now

[H3] Find a Provider Near You
Use our search tool to locate healthcare providers in your area who can help manage your migraine attacks.

start your search

IMPORTANT SAFETY INFORMATION
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Have high blood pressure
Have circulation problems in your fingers and toes
Have liver problems
Have kidney problems
Are pregnant or plan to become pregnant
Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100

Please see full Patient Information.

[H2] SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU
Use telemedicine to connect to a doctor. Here's how:

[IMG: chat bubbles icon]
Answer a few simple questions about your migraine attacks and current treatment plan.
[IMG: stethoscope inside phone icon]
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
[IMG: rx paper icon]
If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.

*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW

BACK TO SITE

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H2] YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue

Cancel

[H1]

US-UBR-250117

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

This offer is valid for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient.
This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. If at any time a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for this program and must cease participation. This offer is not valid for cash-paying patients.
Eligible commercially insured patients may pay as little as $0 per monthly prescription fill. Patient out-of-pocket expense will vary; check with your pharmacist for your co-pay discount. Restrictions, including monthly, quarterly, and/or annual maximums, may apply.
Subject to all other terms and conditions, a commercially insured patient whose plan covers UBRELVY may receive up to a maximum annual savings of $7,000 per calendar year, solely for the patient’s benefit, under this program. Commercially insured patients for whom coverage is not available because the insurer has not established a coverage review process may be eligible to receive up to 4 one-month fills at no charge. Under this program, once an insurer has established a review process for coverage requests, commercially insured patients may receive up to a maximum of 2-month fills at no charge for an FDA-approved indication while coverage is pending.
Patients may not seek reimbursement for value received from this savings program from any third-party payers.
AbbVie reserves the right to rescind, revoke, or amend this offer without notice.
Offer good only in the USA, including Puerto Rico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states may not be eligible to participate in this program.
Void if prohibited by law, taxed, or restricted.
This card is not transferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.
This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.
This offer is not health insurance.
By redeeming this offer, you acknowledge that you are an eligible commercially insured patient and that you understand and agree to comply